A year af­ter em­bark­ing on a new HQ and man­u­fac­tur­ing site, Ab­Cellera starts sec­ond phase of its build­out

A year ago, Cana­di­an an­ti­body biotech Ab­Cellera broke ground on the first phase of its head­quar­ters ex­pan­sion in Van­cou­ver, along with a new man­u­fac­tur­ing site in the city. Now, the com­pa­ny is forg­ing ahead with the sec­ond part of the project.

The com­pa­ny has bro­ken ground on the next phase build­ing out what will ul­ti­mate­ly be a 380,000-square-foot cam­pus. Ab­Cellera hopes to in­clude lab and of­fice space to sup­port its work in an­ti­body de­vel­op­ment.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.